Detection of new drug indications from electronic medical records

@article{Dang2016DetectionON,
  title={Detection of new drug indications from electronic medical records},
  author={Tran-Thai Dang and Phetnidda Ouankhamchan and Tu-Bao Ho},
  journal={2016 IEEE RIVF International Conference on Computing & Communication Technologies, Research, Innovation, and Vision for the Future (RIVF)},
  year={2016},
  pages={223-228}
}
Drug repositioning — detection of new uses of existing drugs — is an emerging trend in pharmaceutical industry. It essentially is a multiple aspect process of analyzing large-scale heterogeneous data for exploiting advantage of off-targets of the existing drugs. Three kinds of omics, phenomic and drug data are often integrated and used to study drug repositioning. The recent prevalence of electronic medical records (EMRs) makes it become an extremely significant resource of phenomic data for… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

A survey of current trends in computational drug repositioning;

  • J. Li, S. Zbeng, B. Chen, A. Butte, S. Swarnidass, Z. Lu
  • Briefings in bioinformatics,
  • 2016
1 Excerpt

Similar Papers

Loading similar papers…